Brian Feagan

Increased Intestinal Permeability Is Associated With Later Development of Crohn’s Disease

Williams Turpin, Sun-Ho Lee, Juan A. Raygoza Garay et al. · Gastroenterology · 2020 · 289 citations

Inflammation, Chronic Inflammatory Diseases, Intestinal Permeability Is +11

American Gastroenterological Association Consensus Development Conference on the Use of Biologics in the Treatment of Inflammatory Bowel Disease, June 21–23, 2006

Jean‐Frédéric Colombel, Brian Feagan, Richard N. Fedorak et al. · Gastroenterology · 2007 · 228 citations · Full text

Inflammation, Translational Medicine, Mucosal Immunology +6

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 89 citations · Full text

Inflammation, Anti-inflammatory, Immunology +7

A Randomized Trial of Methotrexate in Combination With Infliximab for the Treatment of Crohn's Disease

Brian Feagan, John WD McDonald, Remo Panaccione et al. · Gastroenterology · 2008 · 79 citations

Anti-inflammatory, Immunology, Gastroenterology +4

Management of Recent Onset Crohn’s Disease: A Controlled, Randomized Trial Comparing Step-up and Top-down Therapy

Daniël W. Hommes, Filip Baert, Gert Van Assche et al. · Gastroenterology · 2005 · 57 citations · Full text

Gastroenterology, Clinical Gastroenterology, Top-down Therapy +3